vimarsana.com

Page 68 - இந்தியன் சபை க்கு மருத்துவ ஆராய்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Antiviral drug Clevira repurposed for treating mild to moderate COVID-19 cases

CCMB comes up with new COVID-19 testing method using dry swab

CCMB comes up with new COVID-19 testing method using dry swab ANI | Updated: Apr 30, 2021 14:42 IST Hyderabad (Telangana) [India], April 30 (ANI): Rakesh Mishra, Director of Center for Cellular and Molecular Biology (CCMB), on Friday said that they have come up with a new way of collecting COVID-19 samples using a dry swab technique/method for testing. Speaking to ANI, Mishra said that the new method is cheap, safe, fast and more accurate compared to methods already in use. He further stated that using the dry swab method, a 300 per cent increase in the number of tests conducted on a daily basis can be expected.

India s new phase of Covid-19 vaccination is neither liberalised nor accelerated

Representational image. | Rupak De Chowdhuri / Reuters Indians are “dropping dead like flies” and the one thing that the government had promised – perhaps the only thing that can save the country right now – has proven to be nothing more than a farce. On April 19, around two weeks after the disastrous second wave of Covid-19 picked up pace in India, the Narendra Modi government calmed many nerves by announcing a “transparent, liberalised and accelerated” phase three of its vaccination drive that would make all Indian adults eligible to get the jab. Over the last 10 days, even as the number of new cases rose sharply – at over 3,79,000 on April 28 – and thousands of Indians lost their lives as they ran from pillar to post in search of medicines and doctors, there was a ray of hope that come April 28, the registration for phase 3 will open, and the crisis will be brought under control.

Antiviral drug Clevira repurposed for treating mild to moderate COVID-19 patients

Antiviral drug Clevira repurposed for treating mild to moderate COVID-19 patients The drug is effective when taken orally and the dosage is one tablet twice daily after food for 14 days. Share Via Email   |  A+A A- Beds lie inside an indoor stadium converted into COVID-19 treatment center for emergencies in the wake of the spike in the numbers of positive coronavirus cases in Srinagar. (Photo | AP) By PTI NEW DELHI: Clevira, a drug primarily developed to treat dengue, has been repurposed as supportive treatment for mild to moderate COVID-19 cases, its manufacturer Apex Laboratories Private Limited said on Friday. The drug is effective when taken orally and the dosage is one tablet twice daily after food for 14 days.

ICMR said Do not eat any medicine like this which can increase the severity of corona infection more

ICMR said Do not eat any medicine like this which can increase the severity of corona infection more
jagran.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jagran.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.